OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Headache and Pain is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Real-World experience of interictal burden and treatment in migraine: a qualitative interview study	324
CGRP-dependent sensitization of PKC-δ positive neurons in central amygdala mediates chronic migraine	138
Two-year effectiveness of erenumab in resistant chronic migraine: a prospective real-world analysis	110
Using natural language processing to automatically classify written self-reported narratives by patients with migraine or cluster headache	85
Premonitory symptoms in migraine: a systematic review and meta-analysis of observational studies reporting prevalence or relative frequency	77
Efficacy of erenumab and factors predicting response after 3 months in treatment resistant chronic migraine: a clinical service evaluation	71
Debate: Are cluster headache and migraine distinct headache disorders?	65
Pre-pregnancy migraine diagnosis, medication use, and spontaneous abortion: a prospective cohort study	60
Visual stimulation and frequency of focal neurological symptoms engage distinctive neurocognitive resources in migraine with aura patients: a study of resting-state functional networks	60
Trigeminal ganglion itself can be a viable target to manage trigeminal neuralgia	56
Similarities and differences between SUNCT and SUNA: a cross-sectional, multicentre study of 76 patients in China	48
Dopamine receptor D2 regulates GLUA1-containing AMPA receptor trafficking and central sensitization through the PI3K signaling pathway in a male rat model of chronic migraine	47
CGRP and PACAP-38 play an important role in diagnosing pediatric migraine	43
Measuring interictal burden among people affected by migraine: a descriptive survey study	42
Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results	41
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients	41
Hypoperfusion in nucleus accumbens in chronic migraine using 3D pseudo-continuous arterial spin labeling imaging MRI	38
Total tenderness score and pressure pain thresholds in persistent post-traumatic headache attributed to mild traumatic brain injury	37
One-quarter of individuals with weekly headache have never consulted a medical doctor: a Danish nationwide cross-sectional survey	35
A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States	34
Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study	33
Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phas	32
Gamma-aminobutyric acid and glutamate/glutamine levels in the dentate nucleus and periaqueductal gray with episodic and chronic migraine: a proton magnetic resonance spectroscopy study	32
Migraine epidemiology and comorbidities in Southern Israel: a clinical database study in a universal health coverage setting	32
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study	32

HMGB1 in the mPFC governs comorbid anxiety in neuropathic pain	31
Cerebral blood flow alterations in migraine patients with and without aura: An arterial spin labeling study	30
Development and validation of a novel model for characterizing migraine outcomes within real-world data	29
The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients	29